IBUPROFEN-CAFFINE COMBINATIONS

摘要

This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation in mammals, including humans, by administering compositions comprising (i) an analgesically and anti-inflammatory effective amount of a salt of (S)-ibuprofen substantially free of (R)-ibuprofen wherein the salt is selected from (S)-ibuprofen-(S)-lysine and (S)-ibuprofen- (R)-lysine; and (ii) an amount effective in the enhancement of pain relief of caffeine.